SER- Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. SER is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.33M | $6.03M | - | |
| CEO | 230.1K | $416.5K | - | |
| Dir | 92.0K | $166.5K | - | |
| VP | 85.6K | $154.9K | - | |
| Dir | 10.1K | $18.3K | +10.1K |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Wilson Karen J | Director | Buy | 10,100 | $1.76 | $17,749.50 | +198.0% | - | - | |
| May 22, 2026 | Venkatesan Jay | Director | Buy | 589 | $1.78 | $1,048.42 | New | - | - | |
| Mar 23, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 6,500 | $2.86 | $18,567.90 | -100% | -33.3% | - | |
| Mar 19, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 39,000 | $2.50 | $97,500.00 | -100% | -20.2% | - | |
| Feb 2, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 6,500 | $3.03 | $19,680.05 | -100% | -33.2% | - | |
| Jan 28, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 6,500 | $3.57 | $23,185.50 | -100% | -32.0% | - | |
| Jan 22, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 2,500 | $2.95 | $7,375.00 | -100% | - | - | |
| Jan 21, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 4,000 | $3.04 | $12,140.00 | -100% | - | - | |
| Jan 14, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 6,500 | $2.50 | $16,253.36 | -100% | -25.8% | - | |
| Jan 8, 2026 | Moreadith Randall73 | Chief Scientific Officer | Sale+OE | 13,000 | $2.69 | $34,953.10 | -100% | -22.9% | - |
Page 1Next →